Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-25 @ 1:21 AM
NCT ID: NCT06899893
Eligibility Criteria: Inclusion Criteria: 1. Initial stroke onset \<6 months, or the last stroke event occurred more than 6 months ago; 2. Age ≥18 years, \<85 years (the likelihood of VCI increases beyond 85 years); 3. Patients with lesions in the middle cerebral artery region; 4. NIHSS \>4, NIHSS \<26; 5. mRS score ≥2; 6. Completion of CT or MRI; 7. No severe neurological or psychiatric disorders; no impairment of consciousness, able to cooperate with relevant treatments; no severe cognitive impairment (MMSE ≥15); 8. All participants are right-handed; 9. Signed informed consent form. Exclusion Criteria: 1. History of epilepsy or psychiatric disorders (including depression, anxiety, or schizophrenia); 2. Severe comorbidities; 3. History of medication use: benzodiazepines, baclofen, or antidepressants; 4. Non-compliance with the protocol; 5. Acute phase of cerebral hemorrhage or acute infectious diseases; 6. Severe suicidal tendencies in patients with depression; 7. Severe headache, hypertension, malignant tumors, open wounds, vascular embolism, leukopenia, or other serious conditions; 8. Severe alcohol abuse; 9. History of cranial surgery or presence of metal implants in the brain; 10. Patients with cardiac pacemakers; 11. NIHSS \> 26 or MMSE \< 15; 12. Any condition likely to result in the patient's survival for less than 1 month; 13. Pregnancy.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT06899893
Study Brief:
Protocol Section: NCT06899893